Activation of diverse signalling pathways by oncogenic PIK3CA mutations.
about
Somatic Activating PIK3CA Mutations Cause Venous MalformationPhosphoproteomic Profiling Reveals Epstein-Barr Virus Protein Kinase Integration of DNA Damage Response and Mitotic SignalingBenchmarking substrate-based kinase activity inference using phosphoproteomic data.The butterfly effect in cancer: a single base mutation can remodel the cell.High-throughput identification of proteins with AMPylation using self-assembled human protein (NAPPA) microarrays.Proteogenomics connects somatic mutations to signalling in breast cancer.Activating PIK3CA Mutations Induce an Epidermal Growth Factor Receptor (EGFR)/Extracellular Signal-regulated Kinase (ERK) Paracrine Signaling Axis in Basal-like Breast Cancer.Towards standardization of next-generation sequencing of FFPE samples for clinical oncology: intrinsic obstacles and possible solutions.Activating Mutations in PIK3CA Lead to Widespread Modulation of the Tyrosine Phosphoproteome.Identification of significantly mutated regions across cancer types highlights a rich landscape of functional molecular alterationsRES-529: a PI3K/AKT/mTOR pathway inhibitor that dissociates the mTORC1 and mTORC2 complexes.Integrated tumor and germline whole-exome sequencing identifies mutations in MAPK and PI3K pathway genes in an adolescent with rosette-forming glioneuronal tumor of the fourth ventricle.Pancancer modelling predicts the context-specific impact of somatic mutations on transcriptional programs.Chronic exposure to cigarette smoke leads to activation of p21 (RAC1)-activated kinase 6 (PAK6) in non-small cell lung cancer cells.Altered signaling associated with chronic arsenic exposure in human skin keratinocytes.Correlation between PIK3CA mutations in cell-free DNA and everolimus efficacy in HR+, HER2- advanced breast cancer: results from BOLERO-2.Quantitative phosphoproteomic analysis of the PI3K-regulated signaling network.Quantitative proteomics using SILAC: Principles, applications, and developments.PIK3CA mutations and TP53 alterations cooperate to increase cancerous phenotypes and tumor heterogeneity.Phosphoproteomic comparison of Pik3ca and Pten signalling identifies the nucleotidase NT5C as a novel AKT substrate.A butterfly effect in cancer.Role of the E3 ubiquitin ligase RNF157 as a novel downstream effector linking PI3K and MAPK signaling pathways to the cell cycle.Cortactin in Atherosclerosis: Just Say NO.AMP-Activated Protein Kinase and Sirtuin 1 Coregulation of Cortactin Contributes to Endothelial Function.Cortactin function in invadopodia.Quantitative phosphoproteomic analysis reveals reciprocal activation of receptor tyrosine kinases between cancer epithelial cells and stromal fibroblasts.
P2860
Q28270654-942F81A4-124D-4A8B-94B3-A685E8E9403AQ28551996-B9406E6D-D440-4BA0-B3C4-FB79DEF2EB4FQ31162178-C84CB1AD-3F06-4309-9D6D-6C96D14A0AEFQ35037970-0BBCF821-4EF2-4087-805C-AC017234E985Q35731284-8938733C-B2F5-4814-AB59-33B65E60AFCFQ36037203-D8800C43-2F17-4479-849B-E67C729B9DB7Q36103879-BB47657D-1F63-45FE-B575-ACC9FA5CCE3EQ36264188-3115B1AA-F154-4A79-AE43-A443B7C6C10AQ36271077-A4BD7C4F-5618-4332-910D-D23C092E8072Q36515529-39BCD729-FE06-473E-974E-4877A2180213Q36939659-D17C79C7-C194-463E-BA8F-BCEAAA9EB263Q37212868-EE4CB981-1687-4D24-A59A-A0363B1D1132Q37622585-73BA8E05-31E3-488D-AEBD-58E3CE2DD174Q37641586-C30C0D72-7C91-492E-ABB6-5DC066A82AE8Q38373554-2E0BFF8C-D8F0-4A28-ADFC-EBFF6BB9AABDQ38376017-333658F8-07DE-4F96-BAAF-C9225C053CBFQ38391539-9148F76C-F501-4E1F-A6C3-C6620E4952E6Q38533946-942D5F77-F60D-4202-B009-906108D35FCFQ38716747-0287BF05-8D91-4831-92EA-1014A8B8AFFFQ39036639-F5740746-CC11-436A-80B1-1A064CE5D691Q40630278-63E23DB3-C4A0-44D0-BD4E-84C6D2983FA6Q41603456-56F9EFEC-BA8C-4170-9103-553143CB2A98Q45011816-D3EFA60A-B0CF-4123-95F9-20B0C192BA68Q46044599-7814D7E4-90E0-408F-8FB9-BAB006BBD75EQ47367433-041AA2F1-C8AF-4A74-B5D2-3D71A81BCB4AQ55317564-491118D4-29C7-45AF-9ABC-3F584AA94354
P2860
Activation of diverse signalling pathways by oncogenic PIK3CA mutations.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Activation of diverse signalling pathways by oncogenic PIK3CA mutations.
@ast
Activation of diverse signalling pathways by oncogenic PIK3CA mutations.
@en
Activation of diverse signalling pathways by oncogenic PIK3CA mutations.
@nl
type
label
Activation of diverse signalling pathways by oncogenic PIK3CA mutations.
@ast
Activation of diverse signalling pathways by oncogenic PIK3CA mutations.
@en
Activation of diverse signalling pathways by oncogenic PIK3CA mutations.
@nl
prefLabel
Activation of diverse signalling pathways by oncogenic PIK3CA mutations.
@ast
Activation of diverse signalling pathways by oncogenic PIK3CA mutations.
@en
Activation of diverse signalling pathways by oncogenic PIK3CA mutations.
@nl
P2093
P2860
P50
P356
P1476
Activation of diverse signalling pathways by oncogenic PIK3CA mutations.
@en
P2093
Akhilesh Pandey
Babu Lal Somani
Ben Ho Park
Edward Gabrielson
Jiang Qian
Johnathan Neiswinger
Jun-Seop Jeong
Maureen A Powers
P2860
P2888
P356
10.1038/NCOMMS5961
P407
P577
2014-09-23T00:00:00Z
P5875
P6179
1003326877